Innovent Biologics, Inc. (HKG:1801)
102.40
+1.20 (1.19%)
Aug 21, 2026, 4:08 PM HKT
Innovent Biologics Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Innovent Biologics stock has a consensus rating of "Strong Buy" and an average price target of $118.52. The average 1-year stock price forecast is 15.74% higher than the current stock price, while the lowest is $94.26 (-7.95%) and the highest is $140.72 (+37.42%).
Price Target: $118.52 (+15.74%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Innovent Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 21 | 22 | 22 | 22 | 21 | 21 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 3 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 30 | 29 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| DBS | DBS | Buy Initiates $144.00 | Buy | Initiates | $144.00 | +40.62% | Aug 18, 2026 |
Unknown Analyst Daiwa No rating | Daiwa | Buy Maintains $120.00 | Buy | Maintains | $120.00 | +17.19% | Aug 12, 2026 |
Unknown Analyst BOCOM International Holdings Company No rating | BOCOM International Holdings Company | Buy Maintains $105.00 → $118.00 | Buy | Maintains | $105.00 → $118.00 | +15.23% | Aug 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $117.00 | Buy | Maintains | $117.00 | +14.26% | Aug 6, 2026 |
Unknown Analyst UOB Kay Hian No rating | UOB Kay Hian | Buy Maintains $112.00 | Buy | Maintains | $112.00 | +9.37% | Jul 16, 2026 |
Financial Forecast
Revenue This Year
18.42B
from 13.04B
Increased by 41.27%
Revenue Next Year
22.43B
from 18.42B
Increased by 21.76%
EPS This Year
1.52
from 0.99
Increased by 53.23%
EPS Next Year
1.96
from 1.52
Increased by 29.00%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.